Cargando…

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma

BACKGROUND: Cuproptosis, a newly discovered mode of cell death, has been less studied in hepatocellular carcinoma (HCC). Exploring the molecular characteristics of different subtypes of HCC based on cuproptosis-related genes (CRGs) is meaningful to HCC. In addition, immunotherapy plays a pivotal rol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li, Xu, Jingwei, Chu, Xiufeng, Zhang, Hongqiao, Yao, Xueyuan, Zhang, Jian, Guo, Yanwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667659/ https://www.ncbi.nlm.nih.gov/pubmed/36384423 http://dx.doi.org/10.1186/s12859-022-04997-0

Ejemplares similares

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
por: Ding, Lei, et al.
Publicado: (2022)

Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma
por: Liu, Xianglong, et al.
Publicado: (2022)

Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
por: Chen, Yuqiao, et al.
Publicado: (2023)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer
por: Dong, Hao, et al.
Publicado: (2023)

Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma
por: Wu, Zhaoping, et al.
Publicado: (2023)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Comprehensive Analysis of Cuproptosis Genes and Identification of Cuproptosis Subtypes in Breast Cancer
por: Li, Jialin, et al.
Publicado: (2023)

A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2022)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
por: Peng, Xingyu, et al.
Publicado: (2022)

Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature
por: Zhou, Jinlin, et al.
Publicado: (2023)

Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer
por: Huang, Yan, et al.
Publicado: (2022)

Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
por: Miao, Ye, et al.
Publicado: (2022)

Revealing Prognostic and Immunotherapy-Sensitive Characteristics of a Novel Cuproptosis-Related LncRNA Model in Hepatocellular Carcinoma Patients by Genomic Analysis
por: Mao, Zhenzhen, et al.
Publicado: (2023)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
por: Shi, Yuanxin, et al.
Publicado: (2023)

Novel Molecular Subtyping Scheme Based on In Silico Analysis of Cuproptosis Regulator Gene Patterns Optimizes Survival Prediction and Treatment of Hepatocellular Carcinoma
por: Jiang, Heng, et al.
Publicado: (2023)

Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients
por: Peng, Hong, et al.
Publicado: (2023)

Identification of a cuproptosis and copper metabolism gene–related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma
por: Yuan, Wei, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma
por: He, Fengjiao, et al.
Publicado: (2023)

Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis
por: Wang, Mengxi, et al.
Publicado: (2023)

Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma
por: Jin, Ze, et al.
Publicado: (2022)

Identification of cuproptosis-related molecular subtypes and a novel predictive model of COVID-19 based on machine learning
por: Luo, Hong, et al.
Publicado: (2023)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
por: Huili, Youlong, et al.
Publicado: (2022)

Risk model of hepatocellular carcinoma based on cuproptosis-related genes
por: Liu, Zhiqiang, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
por: Wang, Yufei, et al.
Publicado: (2022)

Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases
por: Ma, Qi, et al.
Publicado: (2022)

Identification of Cuproptosis-Related Subtypes, Establishment of a Prognostic Signature and Characterization of the Tumor Microenvironment in Gastric Cancer
por: Li, Jiazheng, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
por: Li, Duguang, et al.
Publicado: (2023)

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming
por: Nie, Guilin, et al.
Publicado: (2023)

Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
por: Liu, Aibin, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance
por: Pan, Shize, et al.
Publicado: (2022)

A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma
por: Xie, Yusai, et al.
Publicado: (2022)

Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma Immunotherapy
por: Mo, Zhuomao, et al.
Publicado: (2020)

Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma
por: Zhang, Yiping, et al.
Publicado: (2023)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma
por: Liu, Zhili, et al.
Publicado: (2023)

Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer
por: Zhang, Jili, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6qtu7lijd1ir5f65e9cueeg09k